62.75
-0.51(-0.81%)
Currency In USD
| Previous Close | 63.26 |
| Open | 62.95 |
| Day High | 64.32 |
| Day Low | 62.21 |
| 52-Week High | 94.93 |
| 52-Week Low | 51.79 |
| Volume | 1.71M |
| Average Volume | 1.33M |
| Market Cap | 8.47B |
| PE | 24.32 |
| EPS | 2.58 |
| Moving Average 50 Days | 59.32 |
| Moving Average 200 Days | 66.85 |
| Change | -0.51 |
If you invested $1000 in Globus Medical, Inc. (GMED) 10 years ago, it would be worth $2,796.35 as of October 29, 2025 at a share price of $62.75. Whereas If you bought $1000 worth of Globus Medical, Inc. (GMED) shares 5 years ago, it would be worth $1,195.92 as of October 29, 2025 at a share price of $62.75.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Globus Medical Launches ANTHEM™ Elbow Fracture System: A Comprehensive Plating Portfolio for Complex Elbow Trauma
GlobeNewswire Inc.
Oct 14, 2025 8:40 PM GMT
AUDUBON, Pa., Oct. 14, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, has announced the launch of the ANTHEM™ Elbow Fracture System, a fully comprehensive plating portfolio designed to addre
Globus Medical, Inc. Secures Jury Verdict in Delaware Patent Litigation Against Life Spine, Inc.
GlobeNewswire Inc.
Aug 28, 2025 8:30 PM GMT
AUDUBON, Pa., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, announced that a Delaware jury has returned a verdict in favor of Globus in its patent infringement litigation against
Globus Medical Announces Leadership Transitions and Preliminary Second Quarter 2025 Sales Results
GlobeNewswire Inc.
Jul 21, 2025 12:00 PM GMT
AUDUBON, Pa., July 21, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, today announced that Keith Pfeil, Executive Vice President, Chief Operating Officer and Chief Financial Officer, has be